David Owens - Dec 31, 2024 Form 5 Insider Report for Nexalin Technology, Inc. (NXL)

Role
Chief Medical Officer, Director
Signature
/s/ David Owens Name: David Owens, M.D.
Stock symbol
NXL
Transactions as of
Dec 31, 2024
Transactions value $
$2,750
Form type
5
Date filed
1/29/2025, 05:26 PM
Previous filing
Oct 30, 2024
Next filing
Jan 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXL Common stock Purchase $2.75K +1K +0.67% $2.75 149K Dec 20, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXL Stock Option (right to buy) Award $0 +263K $0.00 263K Nov 7, 2024 Common Stock 263K $0.94 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.